The objective of the TL1 Translational Sciences Postdoctoral Program (TSPP) at Washington University is to demystify the processes of commercialization of new technology/translational discoveries by learning how to move projects to the next stage of commercialization and how to establish value-creating milestones, costs, and timelines.
Now accepting applications for the TL1 Postdoctoral Program. Apply by March 1, 2024.
Innovations from bench to bedside
These postdoctoral opportunities are rooted in an exciting culture of start-up companies and the commercialization of biotechnology. In the past two years, St. Louis has been named one of the best start-up cities in the world. St. Louis now hosts a rapidly advancing start-up ecosystem that pairs multiple maker spaces, accelerators, and coworking facilities with larger biotechnology and informatics companies. Together, these create a variety of opportunities for start-up funding at multiple levels. Washington University is a major driver of this exciting local community of biotechnology innovation and commercialization.
The scope of the TL1 program is translational science from bench-to-bedside and bedside-to-bench research. The program has the broad ability to include research projects in late-stage preclinical, first-in-human, clinical, translational, patient-oriented research, population health and community engagement, and biomedical informatics.
Trainees will study the translation of biomedical research into viable technologies and startups. The entrepreneurship focus area better equips trainees to distill and advance the most promising opportunities to improve human health through innovation and entrepreneurship.
Research innovation and technology transfer
Study research innovation and technology transfer trends to identify novel opportunities for future improvement via entrepreneurial activities. Trainees in the technology transfer focus area will learn about patenting, licensing, and technology transfer via didactic and experiential training.
Dissemination and implementation
Learn how to successfully integrate and promote evidence-based interventions in new clinical settings.
Postdoctoral Program for MD or MD/PhD Clinical Fellows
The New TL1 Postdoctoral Program for MD or MD/PhD Clinical Fellows is a two-year program and applicants will typically be in the research portion of their fellowship with an interest in translational and precision health research.
TL1 Postdoctoral Trainees will select courses and participate in mentored experiential learning to compliment research training programs and provide core innovation and entrepreneurship skills. Additional mentorship will be provided through the TL1 Program Directors.
Other benefits of the program include:
- Monthly stipend (up to PGY3)
- Health insurance
- Tuition for coursework: Course tuition is covered through NIH and institutional support. Tuition is provided for graduate-level coursework, including but not limited to: the Certificate in Clinical Investigation, the Master of Science in Clinical Investigation (MSCI), or the Master of Population Health Sciences (MPHS)
- Research funding: Trainees receive a limited amount of funding to use for their research projects throughout the duration of their appointments.
- Travel to national meetings: Funding is available for TL1 Trainees to attend the annual Translational Science National Meeting.
- Clinical Research Training Center (CRTC) resources: All TL1 Trainees have access to the CRTC, which provides computer labs, break-out rooms, classroom, poster printing, and administrative office suites.
- Participation in the Clinical Research Training Center (CRTC) TL1 Program may count toward the requirements of the NIH Loan Repayment Program (LRP). Visit the LRP website for more information.